Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000011

Options or other derivatives

  • COO and SVP, R&D acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · COO and SVP, R&D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-01-02 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +140,000 $2.30 2030-01-01 140,000 140,000 D
Loading xslF345X03/wf-form4_157835923174735.xml…